Efficacy and Safety of Single-session Endoscopic Stone Extraction
- Conditions
- Choledocholithiasis With Acute Cholangitis
- Interventions
- Procedure: single-session ERCPProcedure: two-session ERCP
- Registration Number
- NCT06327126
- Lead Sponsor
- Beijing Friendship Hospital
- Brief Summary
This is a retrospective study, including approximately 600 patients with acute cholangitis accompanied with choledocholithiasis, who treated with single-session or two-session endoscopic stone extraction at Beijing friendship hospital. The investigators assessed the outcomes of single-stage and two-stage endoscopic stone extraction.
- Detailed Description
Acute cholangitis is an acute inflammation caused by obstruction of the bile duct, of which choledocholithiasis is the most common cause. Without timely removal of the obstruction or control of the infection, cholangitis can get worse and even become life-threatening. Therefore, timely and effective treatment is essential for patients with acute cholangitis combined with choledocholithiasis. Endoscopic retrograde cholangiography (ERCP) is used as the first-line treatment for choledocholithiasis-associated acute cholangitis. Previous guidelines recommended two-session endoscopic therapy. Endoscopic biliary drainage as the initial treatment, followed by endoscopic stone extraction after cholangitis improved. In recent years, studies have found that single-session endoscopic stone extraction is safe and effective for patients without serious organ function impairment. Meanwhile, single-session endoscopic lithotomy can avoid the second ERCP intervention, which can relieve the pain of patients, reduce medical costs and shorten the length of hospital stay. However, there is still insufficient evidence on the effectiveness and safety of early single-session ERCP lithotomy. The aim of this study is to evaluate the efficacy and safety of single-session endoscopic stone extraction for acute cholangitis associated with choledocholithiasis, so as to provide reference of clinical treatment.
In a retrospective analysis, approximately 600 patients with acute cholangitis accompanied with choledocholithiasis, who treated with single-session or two-session endoscopic stone extraction at Beijing friendship hospital were studied. The investigators assessed the outcomes of single-stage and two-stage endoscopic stone extraction.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 563
- Age ≥18 years old
- Patients met the Tokyo Guidelines 2018 (TG18) diagnosis of acute cholangitis
- Imaging examination confirmed the presence of choledocholithiasis
- Patients received endoscopic single-session stone extraction or two-session treatment involving stone removal after drainage
- Common bile duct with benign or malignant stenosis
- Changes in the anatomical structure of the stomach or duodenum
- Patients complicated with severe acute pancreatitis
- Patients who underwent endoscopic intervention before admission
- Patients received percutaneous transhepatic cholangio drainage (PTCD) or other invasive interventions besides endoscopic treatment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description single-session treatment group single-session ERCP single-session ERCP two-session treatment group two-session ERCP two-session ERCP
- Primary Outcome Measures
Name Time Method Success rate of complete stone removal during the operation Segmental angiography was performed by balloon closure to determine the presence or absence of negative stone shadow
ERCP-related complication rate from the operation to 1 month after the operation The complications include pancreatitis, hemorrhage, perforation, pneumonia, etc. The results of intraoperative endoscopic observation, postoperative symptoms and signs, blood routine examination, amylase, lipase, and imaging and endoscopic examination were measured.
- Secondary Outcome Measures
Name Time Method Hospital expenses perioperatively Total expenses from admission to discharge.
Length of stay perioperatively Total time from admission to discharge.
Trial Locations
- Locations (1)
Beijing Friendship Hospital
🇨🇳Beijing, Beijing, China